Search

Your search keyword '"Tessari L"' showing total 214 results
Start Over Author "Tessari L"
214 results on '"Tessari L"'

2. Current status of Drosophila suzukii classical biological control in Italy

Author

Lisi, F., Biondi, A., Cavallaro, C., Zappalà, L., Campo, G., Roversi, P. F., Sabbatini Peverieri, G., Giovannini, L., Tavella, L., Tortorici, F., Bardella, S., Carli, C., Bosio, G., Mori, N., Tonina, L., Zanini, G., Caruso, S., Vaccari, G., Masetti, A., Bittau, B., Bariselli, M., Schmidt, S., Falagiarda, M., Bertignono, L., Bonfanti, R., Giorgini, M., Guerrieri, E., Tropiano, F. G., Verrastro, V., Baser, N., Ibn Amor, A., Endrizzi, S., Tessari, L., Puppato, S., Ioriatti, C., Grassi, A., Anfora, G., Fellin, L., Rossi, Stacconi, and M. V.

Subjects
Settore AGR/11 - ENTOMOLOGIA GENERALE E APPLICATA, importation biological control, Parasidoid, host range, IPM, Horticulture, Ganaspis brasiliensis, Ganaspis brasiliensis, host range, invasive species, importation biological control, IPM, parasitoid, parasitoid, invasive species
Published
2022

6. Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network

Author

Agodi, A., Barchitta, M., Auxilia, F., Brusaferro, S., D'Errico, M. M., Montagna, M. T., Pasquarella, C., Tardivo, S., Arrigoni, C., Fabiani, L., Laurenti, Patrizia, Mattaliano, A. R., Orsi, G. B., Squeri, R., Torregrossa, M. V., Mura, I., Aiello, M. R., Alliani, C., Amatucci, M. R., Antoci, M., Antonelli, Massimo, Astuto, M., Arnoldo, L., Arru, B., Baccari, G., Barbadoro, P., Barbara, A., Barilaro, Cynthia, Battaglia, P., Bellocchi, Paolo, Bernasconi, M. O., Bianco, Assunta, Bissolo, E., Bocchi, A., Bruno, A., Brusaferro, M., Buccheri, M., Campanella, F., Canino, R., Cannistra, A., Carini, S. A., Catalano, S., Castellani, P., Castiglione, G., Coniglio, S., Consolante, C., Conte, Caterina, Contrisciani, R., Corallini, R., Crollari, P., Damiani, Gianfranco, Denaro, C., De Remigis, S., Diana, F., Di Bartolo, R., Di Benedetto, A., Di Fabio, G., Di Falco, C., Digeronimo, V., Di Gregorio, P., Distefano, R., Egitto, G., Falciani, E., Farruggia, P., Fenaroli, S., Ferlazzo, G., Garofalo, G., Girardis, M., Giovanelli, Laura, Giubbini, Gabriele, Graceffa, A., Guadagna, A., Gregu, G., Ingala, F., Innocenzi, L., La Camera, G., La Rosa, M. C., Lesa, L., Longhitano, A. M., Luppino, G., Maida, C. M., Manta, G., Marino, G., Masia, M. D., Maviglia, Riccardo, Mazzetti, M., Maugeri, A., Megna, M. T., Mella, L. M., Milazzo, M., Milia, M., Minari, C., Minerva, M., Mordacci, M., Murgia, P., Oliveri, P., Olori, M. P., Pagliarulo, R., Palermo, R., Pandiani, I., Pappalardo, F., Papetti, C., Partenza, A., Pascu, D., Pasculli, M., Pavia, M., Pavone, M. L., Pellegrino, Maria Gabriella, Pelligra, F., Pillon, D., Pintaudi, S., Pitzoi, L., Pinto, A., Piotti, P., Pupo, S., Quattrocchi, R., Righi, E., Rigo, A., Romeo, A., Rosa, Enrico, Rutigliano, S., Sarchi, P., Scimonello, G., Seminerio, A., Stefanini, P., Sticca, G., Taddei, S., Tessari, L., Tetamo, R., Ticca, M., Tribastoni, S., Vallorani, S., Venturoni, F., Vitagliano, E., Vitali, P., Zappone, Assunta, Zei, E., Zeoli, M. P., Laurenti P. (ORCID:0000-0002-8532-0593), Antonelli M. (ORCID:0000-0003-3007-1670), Barilaro C. (ORCID:0000-0002-6576-8921), Bellocchi P., Bianco A., Conte C., Damiani G. (ORCID:0000-0003-3028-6188), Giovanelli L. (ORCID:0009-0007-8931-6253), Giubbini G., Maviglia R., Pellegrino M. G., Rosa E., Zappone A., Agodi, A., Barchitta, M., Auxilia, F., Brusaferro, S., D'Errico, M. M., Montagna, M. T., Pasquarella, C., Tardivo, S., Arrigoni, C., Fabiani, L., Laurenti, Patrizia, Mattaliano, A. R., Orsi, G. B., Squeri, R., Torregrossa, M. V., Mura, I., Aiello, M. R., Alliani, C., Amatucci, M. R., Antoci, M., Antonelli, Massimo, Astuto, M., Arnoldo, L., Arru, B., Baccari, G., Barbadoro, P., Barbara, A., Barilaro, Cynthia, Battaglia, P., Bellocchi, Paolo, Bernasconi, M. O., Bianco, Assunta, Bissolo, E., Bocchi, A., Bruno, A., Brusaferro, M., Buccheri, M., Campanella, F., Canino, R., Cannistra, A., Carini, S. A., Catalano, S., Castellani, P., Castiglione, G., Coniglio, S., Consolante, C., Conte, Caterina, Contrisciani, R., Corallini, R., Crollari, P., Damiani, Gianfranco, Denaro, C., De Remigis, S., Diana, F., Di Bartolo, R., Di Benedetto, A., Di Fabio, G., Di Falco, C., Digeronimo, V., Di Gregorio, P., Distefano, R., Egitto, G., Falciani, E., Farruggia, P., Fenaroli, S., Ferlazzo, G., Garofalo, G., Girardis, M., Giovanelli, Laura, Giubbini, Gabriele, Graceffa, A., Guadagna, A., Gregu, G., Ingala, F., Innocenzi, L., La Camera, G., La Rosa, M. C., Lesa, L., Longhitano, A. M., Luppino, G., Maida, C. M., Manta, G., Marino, G., Masia, M. D., Maviglia, Riccardo, Mazzetti, M., Maugeri, A., Megna, M. T., Mella, L. M., Milazzo, M., Milia, M., Minari, C., Minerva, M., Mordacci, M., Murgia, P., Oliveri, P., Olori, M. P., Pagliarulo, R., Palermo, R., Pandiani, I., Pappalardo, F., Papetti, C., Partenza, A., Pascu, D., Pasculli, M., Pavia, M., Pavone, M. L., Pellegrino, Maria Gabriella, Pelligra, F., Pillon, D., Pintaudi, S., Pitzoi, L., Pinto, A., Piotti, P., Pupo, S., Quattrocchi, R., Righi, E., Rigo, A., Romeo, A., Rosa, Enrico, Rutigliano, S., Sarchi, P., Scimonello, G., Seminerio, A., Stefanini, P., Sticca, G., Taddei, S., Tessari, L., Tetamo, R., Ticca, M., Tribastoni, S., Vallorani, S., Venturoni, F., Vitagliano, E., Vitali, P., Zappone, Assunta, Zei, E., Zeoli, M. P., Laurenti P. (ORCID:0000-0002-8532-0593), Antonelli M. (ORCID:0000-0003-3007-1670), Barilaro C. (ORCID:0000-0002-6576-8921), Bellocchi P., Bianco A., Conte C., Damiani G. (ORCID:0000-0003-3028-6188), Giovanelli L. (ORCID:0009-0007-8931-6253), Giubbini G., Maviglia R., Pellegrino M. G., Rosa E., and Zappone A.

Abstract

Background. Sepsis is the major cause of mortality from any infectious disease worldwide. Sepsis may be the result of a healthcare associated infection (HAI): the most frequent adverse events during care delivery especially in Intensive Care Units (ICUs). The main aim of the present study was to describe the epidemiology of ICU-acquired sepsis and related outcomes among patients enrolled in the framework of the Italian Nosocomial Infections Surveillance in ICUs - SPIN-UTI project. Study design. Prospective multicenter study. Methods. The SPIN-UTI network adopted the European protocols for patient-based HAI surveillance. Results. During the five editions of the SPIN-UTI project, from 2008 to 2017, 47.0% of HAIs has led to sepsis in 832 patients. Overall, 57.0% episodes were classified as sepsis, 20.5% as severe sepsis and 22.5% as septic shock. The most common isolated microorganisms from sepsis episodes were Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. The case fatality rate increased with the severity of sepsis and the mean length of ICU-stay was significantly higher in patients with ICU-acquired sepsis than in patients without. Conclusions. Our study provides evidence that ICU-acquired sepsis occurs frequently in Italian ICU patients and is associated with a high case fatality rate and increased length of stay. However, in order to explain these findings further analyses are needed in this population of ICU patients.

Published
2018

10. Society for Vascular Surgery and American Venous Forum Guidelines on the management of venous leg ulcers: the point of view of the International Union of Phlebology

Author

Mosti, G., Maeseneer, M., Cavezzi, A., Parsi, K., Morrison, N., Nelzen, O., Rabe, E., Partsch, H., Caggiati, A., Simka, M., Obermayer, A., Malouf, M., Flour, M., Maleti, O., Perrin, M., Reina, L., Kalodiki, E., Ferdinando Mannello, Rerkasem, K., Cornu-Thenard, A., Chi, Y. W., Soloviy, M., Bottini, O., Mendyk, N., Tessari, L., Varghese, R., Etcheverry, R., Pannier, F., Lugli, M., Carvallo Lantz, A. J., Zamboni, P., Zuolo, M., Godoy, M. F. G., Godoy, J. M. P., Link, D. P., Junger, M., Scuderi, A., and Dermatology

Subjects
leg ulcer, therapy, venous diseases, Socio-culturale
Published
2015

18. European guidelines for sclerotherapy in chronic venous disorders

Author

Rabe, E., Breu, F. X., Cavezzi, A., Smith, P. Coleridge, Frullini, A., Gillet, J. L., Guex, J. J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A. A., Tessari, L., Pannier, F., Rabe, E., Breu, F. X., Cavezzi, A., Smith, P. Coleridge, Frullini, A., Gillet, J. L., Guex, J. J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A. A., Tessari, L., and Pannier, F.

Abstract

Aim: Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods: This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7-10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines. Results: This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.

Published
2014

20. European guideline for sclerotherapy of varicosis. Part 2: Complications and risks

Author

Rabe, E., Breu, F., Cavezzi, A., Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., Pannier, F., Rabe, E., Breu, F., Cavezzi, A., Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., and Pannier, F.

Published
2014

21. European guideline for sclerotherapy of varicosis. Part 1: Indications and contraindications

Author

Rabe, E., Breu, F., Cavezzi, A., Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., Pannier, F., Rabe, E., Breu, F., Cavezzi, A., Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., and Pannier, F.

Published
2014

28. ICPA: luci ed ombre di uno studio di incidenza

Author

Romano, Gabriele, Montresor, Paolo, Pascu, Diana Sorina, Grattarola, Mario, Tessari, L., Caloi, A., Lorenzoni, Marianna, Mondino, Sara, Tardivo, Stefano, and Mantovani, William

Published
2006

32. European guidelines for sclerotherapy in chronic venous disorders

Author

Rabe, E., Breu, F., Cavezzi, A., Coleridge Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., Pannier, F., Rabe, E., Breu, F., Cavezzi, A., Coleridge Smith, P., Frullini, A., Gillet, J., Guex, J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, Anne-Sylvie, Tessari, L., and Pannier, F.

Abstract

Aim: Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods: This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7-10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines. Results: This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.

Published
2013

39. Europske smjernice za skleroterapiju kod kroničnih venskih poremećaja.

Author

Rabe, E., Breu, F. X., Cavezzi, A., Coleridge Smith, P., Frullini, A., Gillet, J. L., Guex, J. J., Hamel-Desnos, C., Kern, P., Partsch, B., Ramelet, A. A., Tessari, L., and Pannier, F.

Subjects
SCLEROTHERAPY, DRUG therapy, VARICOSE veins, VEIN diseases, PHARMACODYNAMICS, THERAPEUTICS
Abstract

Copyright of Acta Medica Croatica is the property of Croatian Academy of Medical Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2014

40. European guidelines for sclerotherapy in chronic venous disorders.

Author

Rabe, E, Breu, FX, Cavezzi, A, Smith, P Coleridge, Frullini, A, Gillet, JL, Guex, JJ, Hamel-Desnos, C, Kern, P, Partsch, B, Ramelet, AA, Tessari, L, and Pannier, F

Subjects
TREATMENT of vascular diseases, INFORMED consent (Medical law), SCLEROTHERAPY, EVALUATION of medical care, MEDICAL protocols, PATIENT safety, DRUG administration, DRUG dosage
Abstract

The article presents guideline for liquid and foam sclerotherapy drafted on behalf of 23 European Phlebological Societies during a Guideline Conference in Mainz, Germany from May 7-10, 2012. The guideline focuses on sclerosing drugs, sodium tetradecyl sulphate and polidocanol, which are licensed in the majority countries of Europe. The guideline offers recommendations regarding efficacy, side-effects and indications of foam and liquid sclerotherapy of venous malformations and varicose veins.

Published
2014
Full Text
View/download PDF

42. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.

Author

Cavezzi, A. and Tessari, L.

Subjects
*SAPHENOUS vein, *HEALTH outcome assessment, *MEDICAL imaging systems, *HOMOGENEITY, *SCLEROTHERAPY, *CATHETERS, *SURGERY
Abstract

Introduction: Foam sclerotherapy has gained a great popularity among phlebologists worldwide, although a major lack of homogeneity in the material used to produce sclerosant foam (SF) and to inject SF has been reported. Aims: To highlight the literature data and a few personal clinical and experimental outcomes concerning the main variables in SF production and injection. Methods: A review of the published literature and of our own 12 year clinical and experimental experience has been undertaken in order to focus on a few variables of the material and methods used to produce SF with Tessari method and to inject SF. Results: In SF production, differences in gas components, liquid to gas ratio, as well in disposable material can variably influence the resulting SF. Similarly SF injection through ultrasound guidance, with needle, or with short/long catheter may exhibit different foam behaviours according to the variable material and techniques which are employed. More recently the introduction of long catheters, possibly together with hook phlebectomy, seems to potentiate the short-mid term outcomes of foam sclerotherapy. Conclusion: SF formation is greatly influenced by the choice of the gas component, the liquidto- gas ratio, the type of syringes; also larger needles are to be preferred for injection of SF, while long catheters seem to represent a valid alternative especially when combined with tumescence to minimise saphenous diameter. [ABSTRACT FROM AUTHOR]

Published
2009
Full Text
View/download PDF

48. Muscular contracture as a component of low back pain: Evaluation criteria and significance of relaxant therapy

Author

Fassina, A., Alessandro Rubinacci, and Tessari, L.

Subjects
Electrophysiology, Contracture, Piperidines, Back Pain, Muscle Relaxation, Muscles, Posture, Action Potentials, Humans, Biofeedback, Psychology
Abstract

The measurement of diastasis of the spinous processes and of muscular action potentials by means of bio-feedback equipment is a clinically valid means to evaluate the extent of reflex muscular contracture. The methods were used to study the relaxant effect of pridinol mesylate on the lumbar extensor muscles in subjects with acute low back pain. It was found that pridinol mesylate significantly reduced the contracture of the extensor lumbar muscles in low back pain when given per os or parenterally.

Catalog

Books, media, physical & digital resources
See catalog results